PKU start™

References:

1. EFSA NDA Panel, Scientific Opinion on the essential composition of infant and follow-on formulae. EFSA Journal. 2014; 12(7):3760.
2. Raiten D, Talbot J, Waters J. Assessment of nutrient requirements for infant formulas: [LSRO report]. J Nutr. 1998; 28(11).
3. Koletzko B, Baker S, Cleghorn G, et al. Global standard for the composition of infant formula: recommendations of an ESPGHAN coordinated international expert group. J Pediatr Gastroenterol Nutr. 2005; 41(5), 584-99.
4. Singh RH, Cunningham AC, Mofidi S, et al. Updated, web-based nutrition management guideline for PKU: An evidence and consensus based approach. Mol Genet Metab. 2016; 118(2):72-83.
5. Birch EE, et al. The DIAMOND (DHA Intake and Measurement Of Neural Development) Study: a double-masked, randomized controlled clinical trial of the maturation of infant visual acuity as a function of the dietary level of docosahexaenoic acid. Am J Clin Nutr. 2010; 91(4):848-59.
6. Agostoni C, et al. Plasma long-chain polyunsaturated fatty acids and neurodevelopment through the first 12 months of life in phenylketonuria. Dev Med Child Neurol. 2003; 45(4):257-61.
7. Yilmaz O, Cochrane B, Wildgoose J, et al. Phenylalanine free infant formula in the dietary management of phenylketonuria. Orphanet J Rare Dis. 2023: 18;16.